Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Occupational exposure to silica in construction workers: a literature-based exposure database.

Beaudry C, Lavoué J, Sauvé JF, Bégin D, Senhaji Rhazi M, Perrault G, Dion C, Gérin M.

J Occup Environ Hyg. 2013;10(2):71-7. doi: 10.1080/15459624.2012.747399.

PMID:
23252413
2.

Efficacy of surface sampling methods for different types of beryllium compounds.

Dufresne A, Mocanu T, Viau S, Perrault G, Dion C.

J Environ Monit. 2011 Jan;13(1):74-83. doi: 10.1039/c001105c. Epub 2010 Oct 28.

PMID:
20981383
3.

Beryllium aerosol characteristics in the magnesium and aluminum transformation industry in Quebec: a comparison of four different sampling methodologies.

Dufresne A, Dion C, Viau S, Cloutier Y, Perrault G.

J Occup Environ Hyg. 2009 Nov;6(11):687-97. doi: 10.1080/15459620903249828.

PMID:
19757293
4.

Beryllium decontamination with different solvents on different structures.

Dufresne A, Dion C, Viau S, Perrault G.

Ann Occup Hyg. 2009 Oct;53(7):669-75. doi: 10.1093/annhyg/mep047. Epub 2009 Jul 15.

PMID:
19605417
5.

Solvent removal of beryllium from surfaces of equipment made of beryllium copper.

Dufresne A, Turcotte V, Golshahi H, Viau S, Perrault G, Dion C.

Ann Occup Hyg. 2009 Jun;53(4):353-62. doi: 10.1093/annhyg/mep007. Epub 2009 Mar 2.

PMID:
19254960
6.

Personal and static sample measurements of asbestos fibres during two abatement projects.

Dufresne A, Dion C, Frielaender A, Audet E, Perrault G.

Bull Environ Contam Toxicol. 2009 Apr;82(4):440-3. doi: 10.1007/s00128-009-9661-4. Epub 2009 Jan 30.

PMID:
19183819
7.

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.

Depoortère R, Dargazanli G, Estenne-Bouhtou G, Coste A, Lanneau C, Desvignes C, Poncelet M, Heaulme M, Santucci V, Decobert M, Cudennec A, Voltz C, Boulay D, Terranova JP, Stemmelin J, Roger P, Marabout B, Sevrin M, Vigé X, Biton B, Steinberg R, Françon D, Alonso R, Avenet P, Oury-Donat F, Perrault G, Griebel G, George P, Soubrié P, Scatton B.

Neuropsychopharmacology. 2005 Nov;30(11):1963-85.

8.

Investigation of determinants of past and current exposures to formaldehyde in the reconstituted wood panel industry in Quebec.

Lavoué J, Beaudry C, Goyer N, Perrault G, Gérin M.

Ann Occup Hyg. 2005 Oct;49(7):587-602. Epub 2005 Apr 21.

PMID:
15845606
9.

SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit.

Terranova JP, Chabot C, Barnouin MC, Perrault G, Depoortere R, Griebel G, Scatton B.

Psychopharmacology (Berl). 2005 Aug;181(1):134-44. Epub 2005 Apr 14.

PMID:
15830220
10.

Assessment of exposure to quartz, cristobalite and silicon carbide fibres (whiskers) in a silicon carbide plant.

Dion C, Dufresne A, Jacob M, Perrault G.

Ann Occup Hyg. 2005 Jun;49(4):335-43. Epub 2005 Jan 13.

PMID:
15650014
12.
13.

Exaggerated bronchoconstriction due to inhalation challenges with occupational agents.

Malo JL, Cartier A, Lemière C, Desjardins A, Labrecque M, L'Archevêque J, Perrault G, Lesage J, Cloutier Y.

Eur Respir J. 2004 Feb;23(2):300-3.

14.

SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. II: Behavioral profile predictive of an atypical antipsychotic activity.

Depoortere R, Boulay D, Perrault G, Bergis O, Decobert M, Françon D, Jung M, Simiand J, Soubrié P, Scatton B.

Neuropsychopharmacology. 2003 Nov;28(11):1889-902.

15.

SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.

Cohen C, Bergis OE, Galli F, Lochead AW, Jegham S, Biton B, Leonardon J, Avenet P, Sgard F, Besnard F, Graham D, Coste A, Oblin A, Curet O, Voltz C, Gardes A, Caille D, Perrault G, George P, Soubrie P, Scatton B.

J Pharmacol Exp Ther. 2003 Jul;306(1):407-20. Epub 2003 Apr 7.

PMID:
12682217
16.

SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms.

Griebel G, Perrault G, Simiand J, Cohen C, Granger P, Depoortere H, Françon D, Avenet P, Schoemaker H, Evanno Y, Sevrin M, George P, Scatton B.

CNS Drug Rev. 2003 Spring;9(1):3-20. Review.

17.

Proceedings of the first Jack Pepys Occupational Asthma Symposium.

Chan-Yeung M, Malo JL, Tarlo SM, Bernstein L, Gautrin D, Mapp C, Newman-Taylor A, Swanson MC, Perrault G, Jaques L, Blanc PD, Vandenplas O, Cartier A, Becklake MR; American Thoracic Society.

Am J Respir Crit Care Med. 2003 Feb 1;167(3):450-71. No abstract available.

PMID:
12554630
18.

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats.

Cohen C, Perrault G, Voltz C, Steinberg R, Soubrié P.

Behav Pharmacol. 2002 Sep;13(5-6):451-63.

PMID:
12394421
19.

Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents.

Griebel G, Perrault G, Soubrié P.

Psychopharmacology (Berl). 2001 Nov;158(3):241-51.

PMID:
11713613
20.

Adjustment of permissible exposure values to unusual work schedules.

Brodeur J, Vyskocil A, Tardif R, Perrault G, Drolet D, Truchon G, Lemay F.

AIHAJ. 2001 Sep-Oct;62(5):584-94.

PMID:
11669384
21.

The preclinical pharmacologic profile of tiapride.

Scatton B, Cohen C, Perrault G, Oblin A, Claustre Y, Schoemaker H, Sanger DJ, Rouquier L, Porsolt R.

Eur Psychiatry. 2001 Jan;16 Suppl 1:29s-34s.

PMID:
11520476
22.

SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.

Griebel G, Perrault G, Simiand J, Cohen C, Granger P, Decobert M, Françon D, Avenet P, Depoortere H, Tan S, Oblin A, Schoemaker H, Evanno Y, Sevrin M, George P, Scatton B.

J Pharmacol Exp Ther. 2001 Aug;298(2):753-68.

PMID:
11454940
23.

The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety.

Griebel G, Rodgers RJ, Perrault G, Sanger DJ.

Neuropharmacology. 2000 Jul 24;39(10):1848-57.

PMID:
10884565
24.
25.

Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands.

Griebel G, Perrault G, Tan S, Schoemaker H, Sanger DJ.

Behav Pharmacol. 1999 Sep;10(5):483-95.

PMID:
10780255
26.

Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.

Boulay D, Depoortere R, Oblin A, Sanger DJ, Schoemaker H, Perrault G.

Eur J Pharmacol. 2000 Mar 10;391(1-2):63-73.

PMID:
10720636
27.

Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice.

Griebel G, Belzung C, Perrault G, Sanger DJ.

Psychopharmacology (Berl). 2000 Feb;148(2):164-70.

PMID:
10663431
28.

Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect?

Boulay D, Depoortere R, Perrault G, Sanger DJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2000 Jan;24(1):39-49.

PMID:
10659982
29.

Clearance of man made mineral fibres from the lungs of sheep.

Dufresne A, Perrault G, Yamato H, Massé S, Bégin R.

Occup Environ Med. 1999 Oct;56(10):684-90.

30.

The D3 antagonist PNU-99194A potentiates the discriminative cue produced by the D3 agonist 7-OH-DPAT.

Depoortere R, Perrault G, Sanger DJ.

Pharmacol Biochem Behav. 2000 Jan 1;65(1):31-4.

PMID:
10638632
31.

Reduction of oral ethanol self-administration in rats by monoamine oxidase inhibitors.

Cohen C, Curet O, Perrault G, Sanger DJ.

Pharmacol Biochem Behav. 1999 Nov;64(3):535-9.

PMID:
10548268
32.

New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.

Griebel G, Perrault G, Letang V, Granger P, Avenet P, Schoemaker H, Sanger DJ.

Psychopharmacology (Berl). 1999 Sep;146(2):205-13.

PMID:
10525757
33.

Discriminative stimulus effects of drugs acting at GABA(A) receptors: differential profiles and receptor selectivity.

Sanger DJ, Griebel G, Perrault G, Claustre Y, Schoemaker H.

Pharmacol Biochem Behav. 1999 Oct;64(2):269-73. Review.

PMID:
10515302
34.

Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats.

Griebel G, Cohen C, Perrault G, Sanger DJ.

Physiol Behav. 1999 Sep;67(3):315-20.

PMID:
10497947
35.

Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists.

Boulay D, Depoortere R, Perrault G, Borrelli E, Sanger DJ.

Neuropharmacology. 1999 Sep;38(9):1389-96.

PMID:
10471093
36.

Pharmacological studies on synthetic flavonoids: comparison with diazepam.

Griebel G, Perrault G, Tan S, Schoemaker H, Sanger DJ.

Neuropharmacology. 1999 Jul;38(7):965-77.

PMID:
10428415
37.

Orphanin FQ, a novel neuropeptide with anti-stress-like activity.

Griebel G, Perrault G, Sanger DJ.

Brain Res. 1999 Jul 31;836(1-2):221-4.

PMID:
10415424
38.

Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists.

Griebel G, Rodgers RJ, Perrault G, Sanger DJ.

Psychopharmacology (Berl). 1999 May;144(2):121-30.

PMID:
10394992
39.
40.

Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice.

Boulay D, Depoortere R, Rostene W, Perrault G, Sanger DJ.

Neuropharmacology. 1999 Apr;38(4):555-65.

PMID:
10221759
41.
42.
43.
44.

Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.

Griebel G, Perrault G, Sanger DJ.

J Psychopharmacol. 1998;12(4):356-65.

PMID:
10065909
45.
46.

Assessment of the antidepressant-like effects of L-type voltage-dependent channel modulators.

Cohen C, Perrault G, Sanger DJ.

Behav Pharmacol. 1997 Nov;8(6-7):629-38.

PMID:
9832975
50.

Tentative explanatory variable of lung dust concentration in gold miners exposed to crystalline silica.

Dufresne A, Loosereewanich P, Bégin R, Dion C, Ecobichon D, Muir DC, Ritchie AC, Perrault G.

J Expo Anal Environ Epidemiol. 1998 Jul-Sep;8(3):375-98.

PMID:
9679218

Supplemental Content

Loading ...
Support Center